Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 82, Issue 1, Pages 81-94
Publisher
BMJ
Online
2022-11-22
DOI
10.1136/ard-2022-223358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
- (2022) Maarten Boers et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis
- (2022) Lotte van Ouwerkerk et al. ANNALS OF THE RHEUMATIC DISEASES
- Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response
- (2022) Michaël Doumen et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2022) Alexandre Sepriano et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial
- (2021) M. J. J. Lucassen et al. OSTEOPOROSIS INTERNATIONAL
- Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial
- (2021) Veerle Stouten et al. ANNALS OF THE RHEUMATIC DISEASES
- Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis
- (2021) Anthony James Ocon et al. ANNALS OF THE RHEUMATIC DISEASES
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2021) Liana Fraenkel et al. Arthritis & Rheumatology
- Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial
- (2021) Josbert M. Metselaar et al. JOURNAL OF CONTROLLED RELEASE
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
- (2020) Andreas Kerschbaumer et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2020) Alexandre Sepriano et al. ANNALS OF THE RHEUMATIC DISEASES
- Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study
- (2020) Teumzghi F. Mebrahtu et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
- (2020) Gerd R Burmester et al. LANCET
- Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis
- (2020) Li Hua et al. MEDICINE
- Glucocorticoid use is associated with an increased risk of hypertension
- (2020) Ruth E Costello et al. RHEUMATOLOGY
- Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
- (2020) Jianhua Wu et al. BMJ Open Diabetes Research & Care
- Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis
- (2020) Michael D. George et al. ANNALS OF INTERNAL MEDICINE
- The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
- (2020) Gulsen Ozen et al. JOURNAL OF RHEUMATOLOGY
- Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
- (2020) Shahab Abtahi et al. ANNALS OF THE RHEUMATIC DISEASES
- Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis
- (2020) Camille Roubille et al. RHEUMATOLOGY
- Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
- (2020) Merete Lund Hetland et al. BMJ-British Medical Journal
- Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study
- (2020) Mar Pujades-Rodriguez et al. PLOS MEDICINE
- Patient reported outcome data from the Care in Early Rheumatoid Arthritis trial: Opportunities for broadening the scope of treating to target
- (2019) Kristien Van der Elst et al. ARTHRITIS CARE & RESEARCH
- Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA
- (2019) Veerle Stouten et al. RHEUMATOLOGY
- Oral corticosteroid use during pregnancy and risk of preterm birth
- (2019) Kristin Palmsten et al. RHEUMATOLOGY
- Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study
- (2018) Masei Suda et al. CLINICAL RHEUMATOLOGY
- Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis
- (2018) Jessica C. Wilson et al. ARTHRITIS CARE & RESEARCH
- Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data
- (2018) Rebecca M. Joseph et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial
- (2017) Nicole P. C. Konijn et al. RHEUMATOLOGY
- Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
- (2016) Cindy Strehl et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
- (2016) Patrick Verschueren et al. ANNALS OF THE RHEUMATIC DISEASES
- Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis
- (2016) A. Balasubramanian et al. OSTEOPOROSIS INTERNATIONAL
- Clinical Trials Documenting the Efficacy of Low-Dose Glucocorticoids in Rheumatoid Arthritis
- (2015) Theodore Pincus et al. NEUROIMMUNOMODULATION
- Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial
- (2015) Patrick Verschueren et al. ARTHRITIS RESEARCH & THERAPY
- Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
- (2014) P Verschueren et al. ANNALS OF THE RHEUMATIC DISEASES
- Randomized double-blind study of the effect of dexamethasone and methylprednisolone pulse in the control of rheumatoid arthritis flare-up: a preliminary study
- (2014) Vahideh Sadra et al. International Journal of Rheumatic Diseases
- Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study
- (2014) Alper M. van Sijl et al. PLoS One
- Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
- (2013) Marije F. Bakker ANNALS OF INTERNAL MEDICINE
- Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
- (2013) Frank Buttgereit et al. ANNALS OF THE RHEUMATIC DISEASES
- A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
- (2013) Debby den Uyl et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
- (2013) N Duru et al. ANNALS OF THE RHEUMATIC DISEASES
- Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
- (2013) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- (2013) Inmaculada del Rincón et al. Arthritis & Rheumatology
- Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
- (2012) P H de Jong et al. ANNALS OF THE RHEUMATIC DISEASES
- Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis
- (2012) William G Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical Analysis of Chinese Patients With Rheumatoid Arthritis Treated With Leflunomide and Methotrexate Combined With Different Dosages of Glucocorticoid
- (2012) Cong-zhu Ding et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study
- (2012) J. A. Avina-Zubieta et al. RHEUMATOLOGY
- Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study
- (2011) J. A. Avina-Zubieta et al. ANNALS OF THE RHEUMATIC DISEASES
- Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
- (2010) S. L. Gorter et al. ANNALS OF THE RHEUMATIC DISEASES
- Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis
- (2007) P. Verschueren et al. RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now